serena williams tirzepatide EXCLUSIVE: has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview., The 23-time Grand Slam champion Serena Williams Is the Latest

Final Thoughts Retatrutide could be a major development in the world of weight loss treatments, offering a triple-action approach that may outperform existing medicines

A triple agonist activates three different receptors simultaneously

Week 1-4 Mild appetite reduction, possible nausea during initial dose Month 2-3 Noticeable weight loss (5-10% typical), improved satiety Month 4-6 Continued weight loss (10-15% common), stable glucose levels Week 0-0 Weight loss plateau possible, focus on maintenance Week 0-0 Blood sugar improvements within 1-2 weeks Cheat Sheets Featuring GLP-1 (Semaglutide) See how GLP-1 (Semaglutide) fits into a broader research stack with these free downloadable cheat sheets

These include low endogenous concentrations, structural complexity, susceptibility to degradation, and the need for detailed pharmacokinetic and metabolic profiling